How Much of a Cancer Drug Is Too Much? Patients, Researchers Challenge FDA-Approved Dosages

https://www.medscape.com/s/viewarticle/how-much-cancer-drug-too-much-patients-researchers-challenge-2026a1000t3t?ecd=wnl_tp10_daily_260822_MSCPEDIT_etid8619051&uac=148436CN&impID=8619051 Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill.